Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Feb;117(3):463–470. doi: 10.1111/j.1476-5381.1996.tb15213.x

Otilonium: a potent blocker of neuronal nicotinic ACh receptors in bovine chromaffin cells.

L Gandía 1, M Villarroya 1, B Lara 1, V Olmos 1, J A Gilabert 1, M G López 1, R Martínez-Sierra 1, R Borges 1, A G García 1
PMCID: PMC1909307  PMID: 8821535

Abstract

1. Otilonium, a clinically useful spasmolytic, behaves as a potent blocker of neuronal nicotinic acetylcholine receptors (AChR) as well as a mild wide-spectrum Ca2+ channel blocker in bovine adrenal chromaffin cells. 2. 45Ca2+ uptake into chromaffin cells stimulated with high K+ (70 mM, 1 min) was blocked by otilonium with an IC50 of 7.6 microM. The drug inhibited the 45Ca2+ uptake stimulated by the nicotinic AChR agonist, dimethylphenylpiperazinium (DMPP) with a 79 fold higher potency (IC50 = 0.096 microM). 3. Whole-cell Ba2+ currents (IBa) through Ca2+ channels of voltage-clamped chromaffin cells were blocked by otilonium with an IC50 of 6.4 microM, very close to that of K(+)-evoked 45Ca2+ uptake. Blockade developed in 10-20 s, almost as a single step and was rapidly and almost fully reversible. 4. Whole-cell nicotinic AChR-mediated currents (250 ms pulses of 100 microM DMPP) applied at 30 s intervals were blocked by otilonium in a concentration-dependent manner, showing an IC50 of 0.36 microM. Blockade was induced in a step-wise manner. Wash out of otilonium allowed a slow recovery of the current, also in discrete steps. 5. In experiments with recordings in the same cells of whole-cell IDMPP, Na+ currents (INa) and Ca2+ currents (ICa), 1 microM otilonium blocked 87% IDMPP, 7% INa and 13% ICa. 6. Otilonium inhibited the K(+)-evoked catecholamine secretory response of superfused bovine chromaffin cells with an IC50 of 10 microM, very close to the IC50 for blockade of K(+)-induced 45Ca2+ uptake and IBa. 7. Otilonium inhibited the secretory responses induced by 10 s pulses of 50 microM DMPP with an IC50 of 7.4 nM. Hexamethonium blocked the DMPP-evoked responses with an IC50 of 29.8 microM, 4,000 fold higher than that of otilonium. 8. In conclusion, otilonium is a potent blocker of nicotinic AChR-mediated responses. The drugs also blocked various subtypes of neuronal voltage-dependent Ca2+ channels at a considerably lower potency. Na+ channels were unaffected by otilonium. This extraordinary potency of otilonium in blocking nicotinic AChR, unrecognised until now, might account in part for its well known spasmolytic effects.

Full text

PDF
463

Images in this article

468Figure 8
on p.468

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bobo M. H., Magous R., Christen M. O., Bali J. P. Effect of pinaverium and other calcium channel blockers on contraction of isolated gastric antral smooth muscle cells caused by gastrointestinal hormones. Life Sci. 1994;54(25):1947–1954. doi: 10.1016/0024-3205(94)90129-5. [DOI] [PubMed] [Google Scholar]
  2. Criado M., Alamo L., Navarro A. Primary structure of an agonist binding subunit of the nicotinic acetylcholine receptor from bovine adrenal chromaffin cells. Neurochem Res. 1992 Mar;17(3):281–287. doi: 10.1007/BF00966671. [DOI] [PubMed] [Google Scholar]
  3. Fenwick E. M., Marty A., Neher E. Sodium and calcium channels in bovine chromaffin cells. J Physiol. 1982 Oct;331:599–635. doi: 10.1113/jphysiol.1982.sp014394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Feron O., Wibo M., Christen M. O., Godfraind T. Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle. Br J Pharmacol. 1992 Feb;105(2):480–484. doi: 10.1111/j.1476-5381.1992.tb14279.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gandía L., Casado L. F., López M. G., García A. G. Separation of two pathways for calcium entry into chromaffin cells. Br J Pharmacol. 1991 May;103(1):1073–1078. doi: 10.1111/j.1476-5381.1991.tb12302.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garcez-Do-Carmo L., Albillos A., Artalejo A. R., de la Fuente M. T., López M. G., Gandía L., Michelena P., García A. G. R56865 inhibits catecholamine release from bovine chromaffin cells by blocking calcium channels. Br J Pharmacol. 1993 Nov;110(3):1149–1155. doi: 10.1111/j.1476-5381.1993.tb13934.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. García-Guzmán M., Sala F., Sala S., Campos-Caro A., Stühmer W., Gutiérrez L. M., Criado M. alpha-Bungarotoxin-sensitive nicotinic receptors on bovine chromaffin cells: molecular cloning, functional expression and alternative splicing of the alpha 7 subunit. Eur J Neurosci. 1995 Apr 1;7(4):647–655. doi: 10.1111/j.1460-9568.1995.tb00668.x. [DOI] [PubMed] [Google Scholar]
  8. Giachetti A. Pharmacological studies on otilonium bromide. Ital J Gastroenterol. 1991 Nov;23(8 Suppl 1):56–59. [PubMed] [Google Scholar]
  9. Gurney A. M., Rang H. P. The channel-blocking action of methonium compounds on rat submandibular ganglion cells. Br J Pharmacol. 1984 Jul;82(3):623–642. doi: 10.1111/j.1476-5381.1984.tb10801.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  11. Livett B. G. Adrenal medullary chromaffin cells in vitro. Physiol Rev. 1984 Oct;64(4):1103–1161. doi: 10.1152/physrev.1984.64.4.1103. [DOI] [PubMed] [Google Scholar]
  12. Maggi C. A., Manzini S., Meli A. Octylonium bromide: a smooth muscle relaxant which interferes with calcium ions mobilization. Arch Int Pharmacodyn Ther. 1983 Aug;264(2):305–323. [PubMed] [Google Scholar]
  13. Moro M. A., López M. G., Gandía L., Michelena P., García A. G. Separation and culture of living adrenaline- and noradrenaline-containing cells from bovine adrenal medullae. Anal Biochem. 1990 Mar;185(2):243–248. doi: 10.1016/0003-2697(90)90287-j. [DOI] [PubMed] [Google Scholar]
  14. Olivera B. M., Miljanich G. P., Ramachandran J., Adams M. E. Calcium channel diversity and neurotransmitter release: the omega-conotoxins and omega-agatoxins. Annu Rev Biochem. 1994;63:823–867. doi: 10.1146/annurev.bi.63.070194.004135. [DOI] [PubMed] [Google Scholar]
  15. Rang H. P., Colquhoun D., Rang H. P. The action of ganglionic blocking drugs on the synaptic responses of rat submandibular ganglion cells. Br J Pharmacol. 1982 Jan;75(1):151–168. doi: 10.1111/j.1476-5381.1982.tb08768.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Villarroya M., Gandía L., Lara B., Albillos A., López M. G., García A. G. Dotarizine versus flunarizine as calcium antagonists in chromaffin cells. Br J Pharmacol. 1995 Jan;114(2):369–376. doi: 10.1111/j.1476-5381.1995.tb13236.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES